CD Pharma Seeks To License Drugs In India
This article was originally published in PharmAsia News
CD Pharma says it is seeking licensing agreements with large Indian drug makers to introduce four drugs to the nation. Country Manager K.S. Chadha said the VSL Pharmaceuticals subsidiary has four approved drugs ready to market. They include treatments for gastroenterology, gynecology, oral cavity and skin care. The official said CD Pharma also plans to introduce two more products into India within the coming year. The firm specializes in drugs based on probiotics. (Click here for more
You may also be interested in...
Through a licensing-out deal with ORIC for its EGFR/HER2 exon-20 inhibitor, South Korea's Voronoi hopes to gain from its new partner's commercialization experience in NSCLC. The alliance hopes to build a potentially best-in-class presence in a competitive landscape.
An expert panel at the virtual HLTH conference discussed the role of robotics in improving health and wellness in the health continuum. See what Darla Hutton, vice president of US marketing and customer hospital analytics at Intuitive Surgical, said about the future of robotics.
With landmark advisory committee meetings coming up, we take a look back at some of the memorable panel meetings over the last 20 years.